GL Pharmatech Acquires Additional 2 Billion KRW Worth of Shares in Subsidiary GL Pharma
[Asia Economy Reporter Kim Heung-soon] GL Pharmatech announced on the 28th that it will additionally acquire 66,667 shares of its pharmaceutical manufacturing subsidiary GL Pharma for approximately 2 billion KRW. After the stock acquisition, GL Pharmatech's stake in GL Pharma will reach 100%. The scheduled date for the stock acquisition is the same day as the announcement. The company stated that the purpose of this stock acquisition is "operating funds and facility investment funds."
Hot Picks Today
If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- Foreign Media Take Note as Samsung Electronics Averts Strike Crisis: "Concerns Over AI Chip Supply Chain Eased"
- Room Prices Soar from 60,000 to 760,000 Won and Sudden Cancellations: "We Won't Even Buy Water in Busan" — BTS Fans Outraged
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help Us": How Much Do Those Bowing 90 Degrees These Days Actually Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
